Health and Fitness Club Industry News: Other News
Friday, March 24th, 2023
Augie Nieto Dies at Age 65 – Fitness Industry Mogul, Founder of Augie’s Quest to Cure ALS & Hero to ALS Families
Posted: February 24, 2023 in Other News
ORANGE COUNTY, CA - With deep sadness, Augie’s Quest shares the news that its Founder, Beloved Leader and ALS Champion, Augie Nieto, died, surrounded by his family on February 22, 2023, just seven days past his 65th Birthday. Augie was the fitness industry mogul credited for the success of Lifecycle, Life Fitness and Octane Fitness brands. In 2005, at the height of his career, he was diagnosed with amyotrophic lateral sclerosis, or ALS, a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. Read More...
Racing for ALS Celebrates a Big 2022, and Bigger Things to Come in 2023
Posted: December 23, 2022 in Other News
CAMBRIDGE, MA - Racing for ALS had a big 2022, and they’re looking forward to an even bigger 2023. The organization, which rallies auto racing fans across the country to support the fight against ALS, raised more than $700,000 to support ALS research and services this past year. They accomplished this through a series of high-performance driving events, as well as supplementary fundraisers and individual donations from their supporters. Read More...
2022 ALS TDI Summit Presents Updates on Promising Research and Potential Treatments
Posted: October 21, 2022 in Other News
CAMBRIDGE, MA - On October 14, 2022, ALS Therapy Development Institute (ALS TDI) scientists and guest presenters from across the ALS space gathered at the ALS TDI Summit in Boston, to provide the community with updates on research from the past year. They were joined by an audience from across the ALS community, including people with ALS, families, advocates, researchers, pharmaceutical industry professionals and many more who streamed the event online. Read More...
ALS TDI’s 2022 Mid-Year Highlights
Posted: August 17, 2022 in Other News
CAMBRIDGE, MA - Ending ALS will require many treatments to meet the needs of every individual with this disease. As the Drug Discovery Engine for ALS, ALS TDI is solely focused on inventing and discovering treatments until everyone with ALS has access to effective therapies. ALS TDI is proud of the progress that it has made thus far in 2022 and looks forward to continuing to share detailed updates at the 2022 ALS TDI Summit on October 14th. Here are some of our research highlights so far in 2022.... Read More...
Move In May for ALS Awareness Month
Posted: April 18, 2022 in Other News
If you have ever run a race, you know how amazing it feels when you cross that finish line. As a current or future ALS Supporter, it is hoped that you know how crucial funding is to move ALS treatments forward. That's why Augie's Quest hopes you'll the Virtual Race to Cure ALS in honor of May ALS Awareness Month. Choose the activity of your choice! Run, walk, hike or bike any distance, anywhere, anytime between May 22 - 28 and raise critical funds and awareness for ALS. Register Today to Move In May! Read More...
2021 ALS TDI Summit Presents Potential Treatments and Innovative New Technology
Posted: November 17, 2021 in Other News
WATERTOWN, MA - Every year, the ALS Therapy Development Institute (ALS TDI) hosts the ALS TDI Summit as a way to update its community on the state of ALS research and drug discovery at ALS TDI. The Summit program included updates about drug discovery research programs in various stages of development at ALS TDI, as well as an extensive update on Project Euphonia, an initiative from Google to develop communication tools for people with conditions that affect their speech like ALS that was launched in collaboration with ALS TDI. ALS TDI also paid tribute to outstanding members of the ALS community with the annual Leadership Awards. Read More...
Augie’s Quest and Myzone 2021 MEPS Challenge
Posted: October 24, 2021 in Other News, Suppliers
DENVER, CO and U.K. - Myzone is again linking up with Augie's Quest for a special 45-day Augie’s Quest Challenge for your club’s staffs that starts on November 1. The Challenge is a fundraiser for Augie’s Quest, and you can easily enter a team of seven staff to compete in this national challenge for a total donation of $349. Read More...
Phase 2 Trial of ALS TDI-Invented AT-1501 Almost Fully Enrolled
Posted: September 9, 2021 in Other News
CAMBRIDGE, MA - A phase 2 trial of AT-1501, a potential ALS treatment invented the ALS Therapy Development Institute (ALS TDI), is almost fully enrolled according to its current sponsor, Eledon Pharmaceuticals. AT-1501 (antiCD40L) is an antibody therapeutic with comprehensive and promising preclinical data. It blocks specific immune cell activation and protects nerves against the progression of ALS and Alzheimer's disease. It is the first potential ALS treatment to be invented by a nonprofit biotech and advanced into human clinical trials. Read More...
Raising ALS Awareness Around the World on International ALS/MND Day
Posted: June 21, 2021 in Other News
CAMBRIDGE, MA - In America, we work to spread awareness of Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig’s Disease, for the entire month of May as part National ALS Awareness Month. However, there is also one single day when the entire world comes together to share the story of this devastating disease, as well as the global effort to both find treatments for it and support those living with ALS. Read More...
Join Augie’s Quest for ALS Awareness Month
Posted: May 4, 2021 in Other News
May is ALS Awareness Month. In May alone, 496 people will be diagnosed with ALS and will be challenged to choose how they spend their remaining years. Every day, Augie Nieto chooses to celebrate and focus on what he can do rather than what he can’t. He has shifted from finding fitness solutions to improve lives to finding a cure to save lives, and he’s still keeping busy, working to achieve that goal. Read More...
ALS TDI Honors Community Members with 2020 ALS Leadership Awards
Posted: November 23, 2020 in Other News
CAMBRIDGE, MA - 2020 has been a year unlike any other. Facing a global pandemic, economic uncertainty, and the realities of lockdowns, quarantines and social distancing, the ALS community still found many creative ways to stay strong and united, even from afar. The support of this community has been incredibly important to keeping research to end Amyotrophic Lateral Sclerosis (ALS) at the ALS Therapy Development Institute (ALS TDI) going, despite the many challenges we’ve all faced this year. Read More...
Novus Therapeutics Announces Enrollment of First ALS Patient in Phase 2 Trials of AT-1501, A Drug Invented at ALS-TDI
Posted: November 2, 2020 in Other News
CAMBRIDGE, MA - The ALS Therapy Development Institute (ALS TDI) is excited to share a significant step in the advancement of AT-1501, a drug invented at ALS TDI, as a potential treatment for people with amyotrophic lateral sclerosis (ALS). Novus Therapeutics, Inc., a clinical stage biopharmaceutical company, has announced that the first subject has been enrolled in the Phase 2a clinical trial evaluating AT-1501 in adults. Read More...
How to Advance ALS TDI’s Latest Discovery in the Lab
Posted: September 30, 2020 in Other News
CAMBRIDGE, MA - The ALS Therapy Development Institute (ALS TDI) recently announced the discovery of a new drug target, Type I PRMTs, for ALS caused by the C9orf72 mutation. We were excited to share those recent findings with the broader ALS research community and with you. We remain in the early days with this discovery, but we are optimistic as we take steps to further advance our findings. Because we can’t complete all of these steps alone, we are developing partnerships to make progress against each of these objectives. However, that progress won’t be possible without the continued support from the ALS community. Read More...
How ALS TDI is Moving Forward with Phase 1 Reopening of Lab
Posted: June 1, 2020 in Other News
CAMBRIDGE, MA - ALS TDI’s Chief Scientific Officer Fernando Vieira, M.D., talks about how ALS TDI is allowing more scientists to enter the lab in accordance with Massachusetts Phase 1 reopening guidelines. ALS TDI thank you for support over the last few months, which has allowed us to maintain the pace of promising ALS research amidst the COVID-19 pandemic. This first week of June, in accordance with the Massachusetts phased reopening guidelines, ALS TDI began allowing more of our scientists and researchers to return to the Cambridge-based lab. While pleased to be able to resume additional operations the safety of staff remains a top priority. Read More...
ALS TDI Study Uncovers New Clue as to Why C9or72 Mutations May Cause Neurodegenerative Disease
Posted: April 17, 2020 in Other News
CAMBRIDGE, MA - It is known that C9orf72 repeat expansion mutations are the most common cause of ALS, but the mechanisms of how and why it causes the disease remain, for the most part, a mystery. However, a new paper by ALS Therapy Development Institute (ALS TDI) scientist, Anna Gill, and several collaborators, may have a promising new clue as to why these C9orf72 mutations may be particularly toxic for brain cells. Read More...
Why COVID-19 Treatments May be Coming in Months, While ALS Research Takes Years
Posted: March 19, 2020 in Other News
CAMBRIDGE, MA - For those who have been waiting years, even decades, for a cure for a disease like ALS, it can be both hopeful and frustrating to hear about the possible rapid development of treatments for COVID-19. Assuming that an effective treatment can be found, there are many reasons why a treatment for an infectious disease like COVID-19 might be easier to develop than one for a condition like ALS. Read More...
Augie’s Quest 15th Annual BASH Event Returns to San Diego
Posted: February 7, 2020 in Other News
SAN DIEGO, CA - Augie’s Quest to Cure ALS, a nonprofit committed to changing the experience of thousands living with amyotrophic lateral sclerosis (ALS) by fast-tracking effective treatments and an ultimate cure, is celebrating their 15th BASH fundraiser by Rockin’ Through the Ages with the fitness industry on March 20. Over 800 guests are expected to attend the event, which is held in conjunction with the International Health, Racquet and Sportsclub Association’s (IHRSA) International Tradeshow and Convention. The BASH represents an opportunity for the fitness industry to come together and celebrate advancements in ALS research, while reminding attendees of the critical hope their support offers for those affected by this disease. Read More...
UFC GYM Partners with Augie’s Quest to Cure ALS
Posted: January 8, 2020 in Chains
LOS ANGELES, CA - UFC GYM members across the United States are aiming to raise more than $250,000 during the post-New Year’s resolution period fitness surge in support of Augie’s Quest to Cure ALS, a nonprofit committed to changing the experience of people living with amyotrophic lateral sclerosis (ALS) by fast-tracking cutting-edge research to advance effective treatments and an ultimate cure. The fundraising campaign runs January 11 through February 8 at participating UFC GYM locations throughout the United States. Read More...
Here’s to Getting 2020 in Focus With Team Quest4ALS!
Posted: December 30, 2019 in Other News
It’s been another incredible year of progress in our quest to end ALS. Thank you for being on this journey with us. Our partners in the fitness industry play such a critical role, flexing your muscles as often as you can for our shared cause. You continue to take on ALS right beside us, stepping up your generous gifts, giving of your time and varied talents and fighting this disease with unmatched passion. You give us hope. And because of you, our dreams of curing ALS are in sight, we’re so much closer to seeing them actually coming true. Read More...
The 15th ALS TDI Leadership Summit
Posted: November 9, 2019 in Other News
CAMBRIDGE, MA - On Friday, November 8, 2019, the ALS Therapy Development Institute (ALS TDI) hosted the 15th Leadership Summit. The Leadership Summit is a full-day conference featuring keynote presentations that provide an in-depth look at the most advanced ALS research. This year, the Summit focused on the groundbreaking research being done at ALS TDI, as well as their exciting collaboration with Google. Read More...
